Before recommending semaglutide, tirzepatide, or another medically supervised weight-loss strategy, a physician may review weight history, prior weight-loss attempts, BMI, waist circumference, body composition goals, A1C, fasting glucose, insulin-resistance risk, cholesterol, triglycerides, blood pressure, liver enzymes, fatty liver risk, kidney function, current medications, diabetes medication use, history of pancreatitis, gallbladder disease, gastrointestinal symptoms, thyroid history, protein intake, exercise habits, sleep quality, hormonal symptoms, inflammation-related concerns, side-effect tolerance, and long-term maintenance planning
Talk to your Found provider or OB-GYN about the best option for you
While clinical trial data for tirzepatide is excellent, some people prefer the longer track record
Within those psychiatric reports, the breakdown is telling
It creates slightly awkward unit numbers for standard doses (62.5 units for 2.5 mg), which makes it harder to measure precisely
Mid estimate assumes 30%